Cerebrovascular Accident (CVA/Stroke) and Cerebral Hemorrhage vs. TIA

🔍 Definition

A Cerebrovascular Accident (CVA), commonly called a stroke, is the sudden onset of neurological deficits caused by disruption of blood supply to the brain — either by ischemia (blockage) or hemorrhage (rupture). Per the American Stroke Association, stroke is the fifth leading cause of death and the leading cause of adult disability in the United States.

There are two major categories for acute stroke coding:

• Ischemic stroke (I63.x): Caused by thrombosis or embolism occluding cerebral or precerebral arteries, accounting for approximately 87% of all strokes. Per CDC stroke statistics, ischemic stroke is the predominant type in Medicare populations.
• Hemorrhagic stroke (I60.x, I61.x, I62.x): Caused by rupture of a blood vessel, leading to subarachnoid hemorrhage (I60.x), intracerebral hemorrhage (I61.x), or other nontraumatic intracranial hemorrhage (I62.x). Higher mortality than ischemic stroke.

A Transient Ischemic Attack (TIA) (G45.x) is a brief episode of neurological dysfunction from focal brain or retinal ischemia, typically lasting less than 1 hour, with no persistent residual effects and no infarction on neuroimaging. TIA is coded separately from stroke and carries distinct HCC implications — critically, TIA is NOT an HCC under CMS HCC v28.

Critical ICD-10-CM distinction: Acute stroke codes (I60–I67) are used for the current acute cerebrovascular disease episode when supported by the encounter and documentation. Subsequent outpatient encounters for persistent neurological deficits use sequelae codes (I69.x), which are the primary HCC drivers for ongoing risk adjustment per FY2027 Official Guidelines Section I.C.9.d.

At-a-Glance: Ischemic vs. Hemorrhagic vs. TIA

Use this quick-reference before code assignment. The three stroke families have distinct code roots, distinct HCCs, and distinct clinical documentation triggers — mis-classification is one of the most common CVA coding errors.

*HCC mapping shown per current CMS-HCC v28 category structure. VERIFY BEFORE PUBLISH — coders should cross-check the current-year CMS-HCC v28 category list at the time of code assignment.

🗂️ Alternative Terminology

Clinical documentation uses a wide variety of terms for stroke, hemorrhage, and related conditions. CDI specialists must recognize these lay and clinical terms and query for specificity when needed.

🩺 Signs & Symptoms

Per the American Stroke Association, stroke symptoms depend on the vessel occluded or ruptured and the brain region affected. Acute stroke symptoms typically have sudden onset.

Acute Stroke Presentation (FAST criteria and beyond)

• Facial droop: Unilateral facial weakness or asymmetry
• Arm weakness: Sudden unilateral arm or leg weakness (hemiparesis/hemiplegia)
• Speech difficulty: Aphasia, dysarthria, slurred speech, word-finding difficulty
• Time/sudden onset: Sudden severe headache “worst headache of life” (SAH hallmark)
• Vision changes: Amaurosis fugax, homonymous hemianopsia, diplopia
• Ataxia/balance: Sudden vertigo, incoordination, gait instability (posterior circulation)
• Altered consciousness: Confusion, stupor, coma (large hemisphere or brainstem involvement)
• Dysphagia: Swallowing difficulty — critical documentation target for HCC 151
• Neglect/inattention: Visuospatial neglect, spatial inattention (right hemisphere)

TIA Distinguishing Features (G45.x)

• Symptoms identical to stroke but resolve completely, typically within minutes and usually less than 1 hour, with no persistent residual effects
• No infarction on DWI-MRI
• ABCD2 score used clinically to risk-stratify short-term stroke risk
• If MRI confirms infarct: code I63.x, NOT G45.x — this distinction is critical per FY2026 ICD-10-CM Official Guidelines

Hemorrhagic Stroke-Specific Features

• SAH (I60.x): Thunderclap headache, meningismus, photophobia, nausea/vomiting, loss of consciousness
• ICH (I61.x): Gradual neurological deterioration over minutes to hours, hypertension hallmark, headache common
• Herniation signs: Ipsilateral pupil dilation, Cushing triad (hypertension, bradycardia, irregular respirations)

🧭 Differential Diagnosis

Accurate differential documentation is essential because several mimics of stroke lead to non-stroke ICD-10-CM codes, yet others are genuine strokes requiring full code specificity with laterality, mechanism, and artery involved.

📋 Clinical Indicators

These clinical indicators should be reviewed at every CVA/TIA encounter to ensure documentation supports the most accurate, specific, and clinically defensible codes possible.

🦴 Anatomy & Pathophysiology

Understanding cerebrovascular anatomy is essential for coders interpreting artery-specific codes and laterality requirements in I63.x and I69.x.

Cerebrovascular Anatomy Relevant to ICD-10-CM

• Anterior circulation (internal carotid artery system): Supplies frontal, parietal, and temporal lobes; includes middle cerebral artery (MCA — most common stroke territory), anterior cerebral artery (ACA)
• Posterior circulation (vertebrobasilar system): Vertebral arteries → basilar artery → posterior cerebral arteries (PCA); supplies brainstem, cerebellum, occipital lobe, thalamus
• Precerebral arteries (I63.0–I63.2, I65.x): Carotid arteries, vertebral arteries, basilar artery — occluded before reaching brain parenchyma
• Cerebral arteries (I63.3–I63.5, I66.x): MCA, ACA, PCA, cerebellar arteries — within brain parenchyma
• Circle of Willis: Anastomotic ring providing collateral flow; significance for code selection when bilateral disease present

Ischemic Stroke Pathophysiology

Per the AHA/ASA 2019 Early Management Guidelines, ischemic stroke mechanisms include:

• Large vessel atherosclerosis (thrombosis): In-situ plaque rupture with thrombosis in carotid, vertebral, basilar, or major cerebral arteries → I63.0xx (precerebral thrombosis) or I63.3xx (cerebral artery thrombosis)
• Cardioembolism: Clot from cardiac source (atrial fibrillation, valvular disease, LV thrombus) → I63.1xx (precerebral embolism) or I63.4xx (cerebral artery embolism); add I48.x for AF
• Small vessel/lacunar disease: Lipohyalinosis or microatheroma in penetrating arteries → subcortical infarcts; code I63.5xx (unspecified) or per mechanism if documented
• Cryptogenic: Undetermined cause; code I63.9 (unspecified cerebral infarction) per provider documentation

Hemorrhagic Stroke Pathophysiology

• Hypertensive ICH (I61.x): Chronic hypertension causes lipohyalinosis of small penetrating arteries (lenticulostriate, thalamoperforators) → microaneurysm formation (Charcot-Bouchard) → rupture; common locations: putamen, thalamus, pons, cerebellum, subcortical white matter
• SAH (I60.x): Most commonly from saccular (berry) aneurysm rupture at Circle of Willis branch points; blood in subarachnoid space → vasospasm → delayed ischemic deficits (code additionally I67.848 if vasospasm documented)
• Cerebral amyloid angiopathy (CAA): Beta-amyloid deposition in vessels → lobar ICH in elderly; code I68.0 (cerebral amyloid angiopathy)

💊 Medication Impact / Treatment

Pharmacological management of CVA/stroke is directly relevant to coding because treatment agents confirm diagnosis (e.g., tPA administration confirms acute ischemic stroke) and some medications have coding implications for adverse effects or documentation.

Acute Ischemic Stroke Reperfusion Therapy

• Alteplase (Activase, tPA) — J2997: IV thrombolysis for acute ischemic stroke within 3–4.5 hours of onset; FDA-approved. Administration confirms I63.x as acute ischemic stroke. Per AHA/ASA 2019 Stroke Guidelines, eligible patients within window benefit significantly. HCPCS J2997 for billing.
• Tenecteplase (TNKase) — J3101: Single-bolus thrombolytic; FDA labeling added acute ischemic stroke as an indication in February 2025; HCPCS J3101 reports injection, tenecteplase, 1 mg. Increasing use due to administration convenience.
• Edaravone (Radicava) — J1301: Free radical scavenger; primarily used in ALS but studied in acute ischemic stroke; document indication clearly.

Antiplatelet and Anticoagulation Therapy

• Aspirin + clopidogrel (DAPT): Used in TIA/minor ischemic stroke (POINT/CHANCE trials); confirm provider documents “TIA” vs. “minor stroke” for accurate code selection
• DOACs (apixaban, rivaroxaban, dabigatran) / Warfarin: Anticoagulation for AF-related stroke prevention; AF coding (I48.x) is essential additional diagnosis when present — HCC 238 for AF under V28
• Heparin/LMWH: Bridging anticoagulation; document indication (DVT prophylaxis vs. cardioembolic source treatment)

Blood Pressure and Neuroprotection

• Permissive hypertension protocol in acute ischemic stroke (maintain BP <185/110 for tPA candidates, <220/120 for non-tPA)
• Acute BP management in spontaneous ICH: per AHA/ASA 2022 guidance, for mild-to-moderate ICH with presenting SBP 150–220 mmHg, lowering SBP to a target of about 140 mmHg and maintaining 130–150 mmHg may be reasonable; avoid lowering SBP below 130 mmHg because it may be harmful
• Statin therapy for secondary prevention in ischemic stroke (document hyperlipidemia E78.5 if present)
• Antiepileptics if post-stroke seizures develop (G40.x — code separately, major CDI opportunity)

Medications Affecting Code Selection

• Anticoagulant use: If hemorrhagic transformation occurs on anticoagulation, provider must document to assign T45.515A/D (adverse effect warfarin) or T45.525A (adverse effect DOAC)
• Nimodipine: Used for SAH to prevent vasospasm; documents SAH present (I60.x)
• Mannitol/hypertonic saline: Documents cerebral edema, brain compression, herniation, or midline-shift risk — for FY2027, midline shift of brain is included under G93.5 (Compression of brain); query only when provider documentation is unclear about the reportable condition or its clinical significance

Preview ends here. The full guide continues with FY2027 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines

The following guidelines govern code selection for cerebrovascular disease per FY2027 ICD-10-CM Official Guidelines, Section I.C.9.d.

Guideline I.C.9.d — Sequelae of Cerebrovascular Disease

• Category I69 is used to indicate conditions classifiable to I60–I67 as the cause of sequelae. Sequelae include conditions specified as such, or as residuals, which may occur at any time after the onset of the causal condition.
• I69.x codes are for outpatient and subsequent encounters — NOT during the acute inpatient admission for the stroke itself.
• Do NOT use I69.x codes with I60–I67 codes in the same encounter unless the patient has a new acute stroke AND separately has residual deficits from a previous stroke — which must be clearly documented by the provider.
• Do NOT assign I69.x if there are no neurological deficits — use Z86.73 (Personal history of TIA and cerebral infarction without residual deficits) instead.
• When a patient has a new stroke and residuals from a prior stroke at the same encounter, both the acute I63.x/I60.x code AND the applicable I69.x code may be assigned — but provider documentation must support both. Intraoperative and postprocedural cerebrovascular accident coding: documentation must clearly specify the cause-and-effect relationship between the medical intervention and the cerebrovascular accident. Code assignment depends on infarction vs. hemorrhage, intraoperative vs. postoperative timing, and, for hemorrhage, the type of procedure performed.

TIA (G45.x) vs. Stroke (I63.x) — Documentation Guideline

• If the provider documents TIA but neuroimaging confirms cerebral infarction: assign I63.x, not G45.x.
• Amaurosis fugax (G45.3) is coded only when the provider documents this specific entity — NOT when permanent vision loss from ischemia is present (code I63.x with vision sequelae I69.x98).
• Transient global amnesia (G45.4) is a separate clinical entity; do not code as TIA unless provider explicitly links to cerebrovascular disease.

Dominant vs. Non-Dominant Side — Official Coding Convention

Per FY2026 ICD-10-CM Tabular instructional notes at categories I69 and G81:

• If documentation does not specify dominant or non-dominant, the default rule is: right side = dominant; left side = non-dominant (for right-handed patients).
• If the left side is affected and left-dominance is documented (left-handed), code as dominant.
• Dominant/non-dominant distinction affects code selection for hemiplegia (I69.x50–I69.x59) and monoplegia (I69.x30–I69.x49).

Laterality — Required 6th Character in I63.x

• Most I63.x codes require laterality in the 6th character: 1 = right side, 2 = left side, 3 = bilateral, 9 = unspecified.
• Assign the most specific laterality supported by provider documentation and neuroimaging reports.
• Artery involvement (MCA, ACA, PCA, vertebral, basilar, etc.) is coded in the 5th character and should be specified from radiology reports or clinical documentation.

🔢 ICD-10-CM Code Set (Tabular)

The following tables present the complete stroke and cerebrovascular code set for FY2027. All codes verified against CMS FY2027 ICD-10-CM Tabular List.

ACUTE STROKE CODES — Inpatient Acute Episode Only

VASCULAR DISEASE — Not Acute Stroke (Status / Stenosis)

TIA CODES — G45.x

SEQUELAE OF CEREBROVASCULAR DISEASE — I69.x (Primary HCC Driver)

History and Additional Codes

🔎 Indexing

Use the FY2027 ICD-10-CM Alphabetic Index with the following lead terms for accurate code selection:

🏥 CPT

The following CPT codes apply to cerebrovascular accident evaluation, diagnosis, and treatment per AMA CPT 2027.

🧾 HCPCS

📚 AHA Coding Clinic

The following AHA Coding Clinic references provide official guidance on cerebrovascular coding. Verify currency against your current Coding Clinic subscription.

💰 HCC / Risk Adjustment

Acute stroke, hemorrhage, and paralytic sequelae map to separate V28 HCCs; history of stroke without deficits does not map. Mappings below follow the 2024 CMS-HCC model (commonly called V28), which CMS uses at 100 percent for non-PACE Medicare Advantage risk scores and continued for CY 2027, and the CMS 2027 Initial ICD-10-CM Mappings. Coefficients vary by enrollee segment and payer, so this guide does not quote RAF weights; check the current CMS model software. Hierarchies are applied by CMS after coding: code every documented, supported condition.

Sources: CMS 2027 Initial ICD-10-CM Mappings (2024 CMS-HCC model, V28); CMS CY 2024 Rate Announcement, Attachment VI (hierarchies, interactions); FY 2027 ICD-10-CM Tabular List, Index, and Official Guidelines. Verified November 3, 2026.

✍️ CDI Query Templates

All query templates below comply with AHIMA and ACDIS standards: non-leading, multiple-choice format, with clinical evidence basis and clear rationale.

🧑‍⚕️ Treatments (Clinical)

Acute Ischemic Stroke Management

Per AHA/ASA 2019 Acute Ischemic Stroke Guidelines:

• IV tPA (alteplase): 0.9 mg/kg (max 90 mg) within 3–4.5 hours of onset for eligible patients; J2997 per mg
• Tenecteplase (TNKase): 0.25 mg/kg IV bolus (max 25 mg); Q5122 per mg; FDA-approved 2024 for ischemic stroke; increasingly preferred in telestroke settings
• Mechanical thrombectomy (CPT 61645): For large vessel occlusion (LVO) up to 24 hours in selected patients with salvageable penumbra per DAWN/DEFUSE-3 criteria; extends treatment window significantly
• Stroke unit care: Dedicated stroke unit with multidisciplinary team reduces mortality and disability per Cochrane meta-analysis
• Antiplatelet therapy: Aspirin 325 mg within 24–48 hours (not within 24 hours of tPA); clopidogrel + aspirin for minor stroke/TIA (21-day DAPT then antiplatelet monotherapy)

Acute Hemorrhagic Stroke Management

• ICH (I61.x): Acute BP management per AHA/ASA 2022 guidance—target about 140 mmHg and maintain 130–150 mmHg for mild-to-moderate ICH with presenting SBP 150–220 mmHg; avoid SBP <130 mmHg; reverse anticoagulation; neurosurgical consultation for cerebellar ICH >3cm (CPT 61305); ICP monitoring/EVD for intraventricular extension (I61.5)
• SAH (I60.x): Aneurysmal SAH — early aneurysm treatment (surgical clipping CPT 61700 or endovascular coiling CPT 61624); nimodipine for vasospasm prevention; TCD monitoring (CPT 93886) for vasospasm; triple-H therapy (hypertension, hemodilution, hypervolemia) for delayed ischemia

Acute Rehab and Post-Acute Care

• Inpatient Rehabilitation Facility (IRF): For patients who can tolerate 3+ hours/day of therapy; codes per IRF-PAI; I69.x sequelae codes are the diagnoses driving admission justification
• Skilled Nursing Facility (SNF): For patients needing 24-hour nursing + therapy but less intensive than IRF
• Physical therapy (CPT 97161–97163, 97110): Gait, balance, lower extremity strengthening for hemiparesis/hemiplegia (I69.x5x)
• Occupational therapy (CPT 97165–97167): Upper extremity function, ADL retraining; cognitive rehabilitation (I69.x1x)
• Speech-language pathology (CPT 92521–92524): Aphasia therapy (I69.x20), dysphagia management (I69.x91 + R13.1x), cognitive-communication treatment
• Constraint-induced movement therapy (CIMT): Evidence-based for upper extremity hemiparesis; document specific deficit (I69.x51/I69.x52) for coverage justification

Secondary Prevention

• Anticoagulation for AF-related stroke (DOAC or warfarin) — reduces recurrence 60–70%
• Carotid endarterectomy (CPT 35301) for symptomatic carotid stenosis ≥50% (I65.2x); carotid stenting CPT 37215 for surgical high-risk patients
• Statin therapy: Intensive LDL lowering; document hyperlipidemia (E78.5) as comorbidity
• Blood pressure control: Target <130/80 post-stroke; document hypertension (I10) as comorbidity
• Diabetes management (E11.x) — major modifiable stroke risk factor

Inpatient MS-DRG Impact

• MS-DRG 061: Ischemic stroke with use of thrombolytic agent with MCC
• MS-DRG 062: Ischemic stroke with use of thrombolytic agent with CC
• MS-DRG 063: Ischemic stroke with use of thrombolytic agent without CC/MCC
• MS-DRG 064–066: Intracranial hemorrhage or cerebral infarction with MCC/CC/without
• MS-DRG 067–069: Nonspecific CVA and precerebral occlusion without infarction
• Mechanical thrombectomy (61645) with I63.x significantly affects reimbursement and resource intensity — document all procedures performed

🎓 Patient Education / Summary

What is a Stroke? (Plain Language)

A stroke is a brain emergency that happens when blood flow to part of the brain is cut off (ischemic stroke — most common) or when a blood vessel ruptures and bleeds into the brain (hemorrhagic stroke). Every minute without treatment, approximately 1.9 million brain cells die per the American Stroke Association — which is why “time is brain” is the central principle of acute stroke care. A TIA (mini-stroke) has the same warning signs but resolves completely; however, TIA is a major warning that a full stroke may follow and requires urgent evaluation.

Key Documentation Points for Patients and Providers

• Acknowledge and document all ongoing deficits at each visit — weakness, speech difficulty, memory problems, swallowing difficulty, facial droop. These are not “history” if they are still present — they are current diagnoses.
• Report new changes promptly — sudden worsening of known deficits may represent recurrent stroke and requires immediate evaluation (911/emergency department)
• Medication adherence — stopping antiplatelet or anticoagulation therapy dramatically increases stroke recurrence risk; document adherence status at each visit
• Risk factor control — blood pressure, blood sugar, cholesterol; all should be documented with current ICD-10-CM codes to support complete risk adjustment
• Driving and safety — many states require reporting of stroke to DMV; hemiplegia/cognitive deficits may affect driving safety; document assessment

Common Patient Misunderstandings That Create Documentation Gaps

• “I had a stroke but I’m fine now” → Often means Z86.73 gets coded, but subtle cognitive, speech, or motor deficits present on examination should be documented as I69.x sequelae if they affect care
• “It was just a TIA, not a real stroke” → If DWI-MRI confirmed infarction, it IS a stroke (I63.x); providers must reconcile clinical impression with imaging findings
• “My left arm weakness is from an old injury” → CDI should ensure provider has distinguished stroke sequelae from unrelated musculoskeletal conditions; provider attestation required
• “I can swallow fine now” → If dysphagia was present and now resolved, document resolution; if still present (even subtle), R13.1x + I69.x91 are appropriate and support HCC 151

Quality Measure Intersections

• CMS STARS — Statin therapy: Post-ischemic stroke patients should be on high-intensity statin; document current statin use + hyperlipidemia (E78.5)
• Atrial fibrillation anticoagulation: AF (I48.x) + stroke history requires anticoagulation documentation; quality measure and HCC capture (HCC 238 under V28)
• Blood pressure control (NQF 0018): Target <130/80 post-stroke; document current BP readings and hypertension management
• Rehabilitation services: Early initiation of PT/OT/SLP improves functional outcomes and supports I69.x sequelae code documentation through therapy notes
• Falls risk assessment: Mandatory for patients with hemiplegia (I69.x5x), ataxia (I69.x93), or gait instability following stroke; Z91.81 history of falling or R29.6 repeated falls

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2027 ICD-10-CM (effective October 1, 2026). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)